Systematic review with meta-analysis: The accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers

Alimentary Pharmacology and Therapeutics

Volumn 42, Issue 5, 2015, Pages 491-503

  Sood, R ^a,b   Gracie, D J ^a,b   Law, G R ^c   Ford, A C ^a,b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN;

DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FECES ANALYSIS; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; META ANALYSIS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SYSTEMATIC REVIEW; DIAGNOSTIC PROCEDURE; INTESTINE ABSORPTION; IRRITABLE BOWEL SYNDROME; PSYCHOLOGICAL AND PSYCHIATRIC PROCEDURES; PSYCHOLOGY; SENSITIVITY AND SPECIFICITY;

BIOMARKERS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; INTESTINAL ABSORPTION; IRRITABLE BOWEL SYNDROME; LEUKOCYTE L1 ANTIGEN COMPLEX; PSYCHOLOGICAL TECHNIQUES; SENSITIVITY AND SPECIFICITY;

EID: 84938551588     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13283     Document Type: Review

References (57)

1. Longstreth GF, Thompson WG, Chey WD, et al,. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
2. Lovell RM, Ford AC,. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712-21 e4.
3. Canavan C, West J, Card T,. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 2014; 40: 1023-34.
4. Chang HC, Yen AM, Fann JC, et al,. Irritable bowel syndrome and the incidence of colorectal neoplasia: a prospective cohort study with community-based screened population in Taiwan. Br J Cancer 2015; 112: 171-6.
5. Halpin SJ, Ford AC,. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2012; 107: 1474-82.
6. Gracie DJ, Kane JS, Mumtaz S, et al,. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol Motil 2012; 24: 983-e538.
7. Sanders DS, Carter MJ, Hurlstone DP, et al,. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling Rome II criteria referred to secondary care. Lancet 2001; 358: 1504-8.
8. Sainsbury A, Sanders DS, Ford AC,. Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis. Clin Gastroenterol Hepatol 2013; 11: 359-65 e1.
9. Shivaji UN, Ford AC,. Beliefs about management of irritable bowel syndrome in primary care: cross-sectional survey in one locality. Prim Health Care Res Dev 2015; 16: 263-9.
10. Thompson WG, Heaton KW, Smyth GT, et al,. Irritable bowel syndrome: the view from general practice. Eur J Gastroenterol Hepatol 1997; 9: 689-92.
11. Sood R, Law GR, Ford AC,. Diagnosis of IBS: symptoms, symptom-based criteria, biomarkers or 'psychomarkers'? Nat Rev Gastroenterol Hepatol 2014; 11: 683-91.
12. Henningsen P, Zimmermann T, Sattel H,. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 2003; 65: 528-33.
13. Creed F, Ratcliffe J, Fernandez L, et al,. Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med 2001; 134 (9 Pt 2): 860-8.
14. Koloski NA, Boyce PM, Talley NJ,. Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study. Eur J Gastroenterol Hepatol 2006; 18: 1101-9.
15. Lee V, Guthrie E, Robinson A, et al,. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation. J Psychosom Res 2008; 64: 129-38.
16. Ford AC, Talley NJ, Veldhuyzen van Zanten SJ, et al,. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? JAMA 2008; 300: 1793-805.
17. Jellema P, van der Windt DA, Schellevis FG, et al,. Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment Pharmacol Ther 2009; 30: 695-706.
18. Diagnostic Test Accuracy Working Group. Handbook for DTA Reviews. Available at: http://srdta.cochrane.org/handbook-dta-reviews (accessed 10 Oct 2014).
19. Moayyedi P, Axon AT,. The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease. Am J Gastroenterol 1999; 94: 3122-5.
20. Whiting PF, Rutjes AW, Westwood ME, et al,. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155: 529-36.
21. Manning AP, Thompson WG, Heaton KW, et al,. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2: 653-4.
22. Jeong H, Lee HR, Yoo BC, et al,. Manning criteria in irritable bowel syndrome: its diagnostic significance. Korean J Intern Med 1993; 8: 34-9.
23. Rao KP, Gupta S, Jain AK, et al,. Evaluation of Manning's criteria in the diagnosis of irritable bowel syndrome. J Assoc Physicians India 1993; 41: 357-8.
24. Dogan UB, Unal S,. Kruis scoring system and Manning's criteria in diagnosis of irritable bowel syndrome: is it better to use combined? Acta Gastroenterol Belg 1996; 59: 225-8.
25. Tibble JA, Sigthorsson G, Foster R, et al,. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002; 123: 450-60.
26. Hammer J, Talley NJ,. Value of different diagnostic criteria for the irritable bowel syndrome among men and women. J Clin Gastroenterol 2008; 42: 160-6.
27. Ford AC, Bercik P, Morgan DG, et al,. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology 2013; 145: 1262-70 e1.
28. Kang JY, Gwee KA, Yap I,. The colonic air insufflation test indicates a colonic cause of abdominal pain. An aid in the management of irritable bowel syndrome. J Clin Gastroenterol 1994; 18: 19-22.
29. Bouin M, Plourde V, Boivin M, et al,. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002; 122: 1771-7.
30. Kim ES, Cheon JH, Park JJ, et al,. Colonoscopy as an adjunctive method for the diagnosis of irritable bowel syndrome: focus on pain perception. J Gastroenterol Hepatol 2010; 25: 1232-8.
31. Crade M, Pham V,. Ultrasound examination of the sigmoid colon: possible new diagnostic tool for irritable bowel syndrome. Ultrasound Obstet Gynecol 2006; 27: 206-9.
32. Lembo AJ, Neri B, Tolley J, et al,. Use of serum biomarkers in a diagnostic test for irritable bowel syndrome. Aliment Pharmacol Ther 2009; 29: 834-42.
33. Jones MP, Chey WD, Singh S, et al,. A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads. Aliment Pharmacol Ther 2014; 39: 426-37.
34. Ahmed I, Greenwood R, Costello Bde L, et al,. An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS ONE 2013; 8: e58204.
35. Ohman L, Stridsberg M, Isaksson S, et al,. Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms? Am J Gastroenterol 2012; 107: 440-7.
36. El-Salhy M, Gilja OH,. Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome. Gastroenterol Res Pract 2014; 2014: 462856.
37. El-Salhy M, Gundersen D, Hatlebakk JG, et al,. Abnormal rectal endocrine cells in patients with irritable bowel syndrome. Regul Pept 2014; 188: 60-5.
38. Camilleri M, Shin A, Busciglio I, et al,. Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil 2014; 26: 1677-85.
39. Spiller RC, Humes DJ, Campbell E, et al,. The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease. Aliment Pharmacol Ther 2010; 32: 811-20.
40. Kruis W, Thieme C, Weinzierl M, et al,. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 1984; 87: 1-7.
41. Bellentani S, Baldoni P, Petrella S, et al,. A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. The Local IBS Study Group. Fam Pract 1990; 7: 307-12.
42. Frigerio G, Beretta A, Orsenigo G, et al,. Irritable bowel syndrome. Still far from a positive diagnosis. Dig Dis Sci 1992; 37: 164-7.
43. Lijmer JG, Mol BW, Heisterkamp S, et al,. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999; 282: 1061-6.
44. Ford AC, Moayyedi P, Lacy BE, et al,. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol 2014; 109 (Suppl. 1): S2-26; quiz S7.
45. National Institute for Health and Care Excellence. Irritable bowel syndrome in adults: Diagnosis and management of irritable bowel syndrome in primary care. Available at: http://guidance.nice.org.uk/CG61, 2008 (accessed 10 Oct 2014).
46. Camilleri M, McKinzie S, Busciglio I, et al,. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008; 6: 772-81.
47. Patel P, Bercik P, Morgan DG, et al,. Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating. Aliment Pharmacol Ther 2015; 41: 449-58.
48. Aggarwal VR, McBeth J, Zakrzewska JM, et al,. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors? Int J Epidemiol 2006; 35: 468-76.
49. Devlen J, Beusterien K, Yen L, et al,. The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model. Inflamm Bowel Dis 2014; 20: 545-52.
50. Iglesias-Rey M, Barreiro-de Acosta M, Caamano-Isorna F, et al,. Psychological factors are associated with changes in the health-related quality of life in inflammatory bowel disease. Inflamm Bowel Dis 2014; 20: 92-102.
51. Sainsbury K, Mullan B, Sharpe L,. Reduced quality of life in coeliac disease is more strongly associated with depression than gastrointestinal symptoms. J Psychosom Res 2013; 75: 135-41.
52. Balestra B, Vicini R, Cremon C, et al,. Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons. Neurogastroenterol Motil 2012; 24: 1118-e570.
53. Tillisch K, Mayer EA, Labus JS,. Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology 2011; 140: 91-100.
54. Manabe N, Wong BS, Camilleri M, et al,. Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort. Neurogastroenterol Motil 2010; 22: 293-e82.
55. Kassinen A, Krogius-Kurikka L, Makivuokko H, et al,. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133: 24-33.
56. van Tilburg MA, Palsson OS, Whitehead WE,. Which psychological factors exacerbate irritable bowel syndrome? Development of a comprehensive model. J Psychosom Res 2013; 74: 486-92.
57. Koloski NA, Jones M, Young M, et al,. Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study. Aliment Pharmacol Ther 2015; 41: 856-66.